Company Filing History:
Years Active: 2011
Title: The Innovations of Satoshi Shimokata: A Study in Chondroitin Production
Introduction
Satoshi Shimokata, an accomplished inventor based in Higashiyamato, Japan, has made significant contributions to the field of biochemistry and molecular biology through his innovative work on chondroitin sugar chain production. With a notable patent to his name, Shimokata's research focuses on the synthesis of long-chain chondroitin, which has far-reaching implications in medical and pharmaceutical applications.
Latest Patents
Satoshi Shimokata holds a patent titled "Long-chain chondroitin sugar chain and method for producing the same and method for promoting synthesis of chondroitin." This method involves a complex reaction between a glucuronic acid donor, an N-acetyl galactosamine donor, a sugar receptor, and a bacterial cell enzyme that synthesizes chondroitin, all facilitated by the presence of a surfactant. The patent specifies various surfactants used in the process, including polyoxyethylene octadecyl amine and n-decanoyl-N-methylglucamide, among others. Notably, the chondroitin sugar chain produced exhibits a weight average molecular weight of 50,000 or more, and is completely degraded to disaccharides through treatment with chondroitinase ABC.
Career Highlights
Satoshi Shimokata has devoted his career to advancing the understanding and production of chondroitin, a vital component in the synthesis of glycosaminoglycans. He is currently associated with Seikagaku Corporation, where he continues to push the boundaries of research in this essential area. His work not only contributes to the scientific community but also promotes innovations within the pharmaceutical industry aimed at improving health outcomes.
Collaborations
Throughout his career, Satoshi Shimokata has collaborated with esteemed colleagues, including Nobuo Sugiura and Koji Kimata. These partnerships have fostered an environment of innovation and shared knowledge, allowing for the advancement of research that significantly impacts the field of medicinal chemistry.
Conclusion
Satoshi Shimokata's contributions serve as a testament to the power of innovation in scientific research, particularly in the development of therapeutic agents derived from chondroitin. His patent not only exemplifies the intricacies of biochemical synthesis but also highlights the importance of collaboration in achieving groundbreaking advancements in healthcare. Through his work, Shimokata continues to inspire future innovations in the realm of biochemistry and beyond.